KRAS and neoplasm: To study tumor suppression by E177R in a different Kras-driven tumor type, we extended our studies with E177R mice and crossed them to KrasLA1 mice which develop lung tumors due to spontaneous activation of a latent oncogenic KrasG12D allele [35].